Patents by Inventor Valerie Masini-Eteve

Valerie Masini-Eteve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal pharmaceutical compositions comprising active agents
    Patent number: 11040043
    Abstract: The present invention provides compositions and methods for providing sustained release of an active agent through the skin of a subject, wherein a pharmaceutical percutaneous composition comprises at least one fatty acid ester and a therapeutically effective amount of active agent.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: June 22, 2021
    Assignee: BESINS HEALTHCARE LUXEMBOURG SARL
    Inventors: Valerie Masini-Eteve, Denis Canet
  • TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING A SERM
    Publication number: 20190380948
    Abstract: The present invention relates to transdermal pharmaceutical compositions such as gels containing a SERM selected from the group consisting of endoxifen, droloxifene, clomifene, raloxifene, tamoxifen, 4-OH tamoxifen, toremifene, danazol and the pharmaceutically acceptable salts thereof, and to methods of making and using the same.
    Type: Application
    Filed: January 14, 2019
    Publication date: December 19, 2019
    Applicant: BESINS HEALTHCARE LUXEMBOURG SARL
    Inventor: Valérie MASINI-ETEVE
  • TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENTS
    Publication number: 20190160077
    Abstract: The present invention provides compositions and methods for providing sustained release of an active agent through the skin of a subject, wherein a pharmaceutical percutaneous composition comprises at least one fatty acid ester and a therapeutically effective amount of active agent.
    Type: Application
    Filed: August 23, 2018
    Publication date: May 30, 2019
    Applicant: Besins Healthcare Luxembourg SARL
    Inventors: Valerie MASINI-ETEVE, Denis CANET
  • Transdermal pharmaceutical compositions comprising active agents
    Patent number: 10080760
    Abstract: The present invention provides compositions and methods for providing sustained release of an active agent through the skin of a subject, wherein a pharmaceutical percutaneous composition comprises at least one fatty acid ester and a therapeutically effective amount of active agent.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: September 25, 2018
    Assignee: BESINS HEALTHCARE LUXEMBOURG SARL
    Inventors: Valerie Masini-Eteve, Denis Canet
  • 4-HYDROXY TAMOXIFEN GEL FORMULATIONS
    Publication number: 20170224639
    Abstract: Pharmaceutical compositions comprising 4-hydroxy tamoxifen in an amount of 0.105-0.950% by weight effectively deliver the 4-hydroxy tamoxifen. Such compositions, including gels, can treat or prevent benign breast disease, scarring or a keloid, gynecomastia, breast cancer, mastalgia, or a condition involving dense breast tissue.
    Type: Application
    Filed: October 14, 2016
    Publication date: August 10, 2017
    Applicant: BESINS HEALTH CARE LUXEMBOURG SARL
    Inventor: Valerie Masini-Eteve
  • Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
    Patent number: 9675698
    Abstract: The present invention relates to a pharmaceutical composition in the form of a hydro-alcoholic gel or a solution for transdermal application, comprising: from about 0.2% to about 1.5% of dihydrotestosterone; and from about 0.2 to about 3% of isopropyl myristate.
    Type: Grant
    Filed: October 11, 2011
    Date of Patent: June 13, 2017
    Assignee: BESINS HEALTHCARE LUXEMBOURG SARL
    Inventors: Valerie Masini-Eteve, Brigitte Taravella
  • Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
    Publication number: 20120157423
    Abstract: The present invention relates to a pharmaceutical composition in the form of a hydro-alcoholic gel or a solution for transdermal application, comprising: from about 0.2% to about 1.5% of dihydrotestosterone; and from about 0.2 to about 3% of isopropyl myristate.
    Type: Application
    Filed: October 11, 2011
    Publication date: June 21, 2012
    Inventors: Valérie Masini-Eteve, Brigitte Taravella
  • PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL OR TRANSMUCOUS ADMINISTRATION
    Publication number: 20120122829
    Abstract: The present invention relates to a novel pharmaceutical composition for transdermal or transmucous administration of at least one active substance, and comprising especially a fatty acid as a percutaneous absorption promoter, at least one alcoholic vehicle and also a stabilizer capable of stabilizing the fatty acid in the said pharmaceutical composition.
    Type: Application
    Filed: January 19, 2012
    Publication date: May 17, 2012
    Inventors: Brigitte Taravella, Valérie Masini-Eteve
  • TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING A SERM
    Publication number: 20120010245
    Abstract: The present invention relates to transdermal pharmaceutical compositions such as gels containing a SERM selected from the group consisting of endoxifen, droloxifene, clomifene, raloxifene, tamoxifen, 4-OH tamoxifen, toremifene, danazol and the pharmaceutically acceptable salts thereof, and to methods of making and using the same.
    Type: Application
    Filed: December 9, 2009
    Publication date: January 12, 2012
    Inventor: Valerie Masini-Eteve
  • TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING DANAZOL
    Publication number: 20110118226
    Abstract: The present invention relates to transdermal danazol-containing pharmaceutical compositions, such as gels, and to methods of making and using the same.
    Type: Application
    Filed: July 24, 2009
    Publication date: May 19, 2011
    Inventor: Valerie Masini-Eteve
  • Transdermal Pharmaceutical Compositions Comprising Active Agents
    Publication number: 20110098258
    Abstract: The present invention provides compositions and methods for providing sustained release of an active agent through the skin of a subject, wherein a pharmaceutical percutaneous composition comprises at least one fatty acid ester and a therapeutically effective amount of active agent.
    Type: Application
    Filed: October 26, 2010
    Publication date: April 28, 2011
    Inventors: Valerie Masini-Eteve, Denis Canet
  • PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL OR TRANSMUCOUS ADMINISTRATION
    Publication number: 20100048526
    Abstract: The present invention relates to a novel pharmaceutical composition for transdermal or transmucous administration of at least one active substance, and comprising especially a fatty acid as a percutaneous absorption promoter, at least one alcoholic vehicle and also a stabilizer capable of stabilizing the fatty acid in the said pharmaceutical composition.
    Type: Application
    Filed: October 30, 2009
    Publication date: February 25, 2010
    Inventors: Brigitte Taravella, Valerie Masini-Eteve
  • TREATMENT AND PREVENTION OF EXCESSIVE SCARRING
    Publication number: 20080220068
    Abstract: A pharmaceutical composition comprised of a hydration agent and an anesthetic can be used to treat excessive scarring conditions, such as keloid and hypertrophic scars.
    Type: Application
    Filed: July 30, 2007
    Publication date: September 11, 2008
    Inventors: Valerie Masini-Eteve, Elisabeth Le Nestour, Jay Bua
  • Liquid Pharmaceutical Compositions Comprising a Bisphosphonate Compound
    Publication number: 20080182822
    Abstract: The present invention relates to liquid pharmaceutical compositions comprising a bisphosphonate compound.
    Type: Application
    Filed: November 16, 2007
    Publication date: July 31, 2008
    Inventor: Valerie MASINI-ETEVE
  • PHARMACEUTICAL COMPOSITIONS COMPRISING A BISPHOSPHONATE COMPOUND
    Publication number: 20080167271
    Abstract: The present invention relates to pharmaceutical compositions comprising a bisphosphonate compound.
    Type: Application
    Filed: November 16, 2007
    Publication date: July 10, 2008
    Inventor: Valerie MASINI-ETEVE
  • 4-Hydroxy tamoxifen gel formulations
    Publication number: 20060105041
    Abstract: Pharmaceutical compositions comprising 4-hydroxy tamoxifen in an amount of 0.105-0.950% by weight effectively deliver the 4-hydroxy tamoxifen. Such compositions, including gels, can treat or prevent benign breast disease, scarring or a keloid, gynecomastia, breast cancer, mastalgia, or a condition involving dense breast tissue.
    Type: Application
    Filed: October 13, 2005
    Publication date: May 18, 2006
    Inventor: Valerie Masini-Eteve
  • Pharmaceutical composition for transdermal or transmucous administration
    Publication number: 20040175416
    Abstract: The present invention relates to a novel pharmaceutical composition for transdermal or transmucous administration of at least one active substance, and comprising especially a fatty acid as a percutaneous absorption promoter, at least one alcoholic vehicle and also a stabilizer capable of stabilizing the fatty acid in the said pharmaceutical composition.
    Type: Application
    Filed: May 12, 2003
    Publication date: September 9, 2004
    Applicant: Besins International Belgique
    Inventors: Brigitte Taravella, Valerie Masini-Eteve
  • Pharmaceutical composition for transdermal or transmucosal administration comprising at least one progestin and/or at least one oestrogen, process for preparing it and uses thereof
    Publication number: 20040110732
    Abstract: The present invention relates to a novel pharmaceutical composition for transdermal or transmucosal administration, comprising
    Type: Application
    Filed: March 20, 2003
    Publication date: June 10, 2004
    Applicant: BESINS INTERNATIONAL BELGIQUE
    Inventors: Valerie Masini-Eteve, Brigitte Taravella
  • Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
    Publication number: 20040072810
    Abstract: The present invention relates to a pharmaceutical composition in the form of a hydro-alcoholic gel or a solution for transdermal application, comprising:
    Type: Application
    Filed: June 6, 2003
    Publication date: April 15, 2004
    Applicant: Besins International Belgique
    Inventors: Valerie Masini-Eteve, Brigitte Taravella
  • Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
    Publication number: 20030087885
    Abstract: The present invention relates to a pharmaceutical composition in the form of a gel or a solution and is characterized in that it contains dihydrotestosterone and also at least one penetration promoter, to processes for preparing it and to uses thereof.
    Type: Application
    Filed: March 13, 2002
    Publication date: May 8, 2003
    Inventors: Valerie Masini-Eteve, Brigitte Taravella